CHSU Discovery

Abstract

Preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality worldwide, affecting approximately 5–8% of all pregnancies. Characterized by new-onset hypertension and signs of end-organ dysfunction, preeclampsia with severe features poses a significant threat to both maternal and fetal health, often requiring early delivery to mitigate risk. Despite growing awareness and advances in obstetric care, cases of rapid clinical decompensation continue to underscore the unpredictable nature of the diseases. This case highlights a patient who developed preeclampsia with severe features at 32 weeks and 3 days of gestation, complicated by pulmonary edema and subsequent postpartum cardiomyopathy. It emphasizes the critical importance of early screening and the application of validated tools to identify patients at risk, guide timely intervention, and prevent serious complications. Through this report, we aim to reinforce the need for vigilant monitoring and evidence-based decision-making in the management of hypertensive disorders of pregnancy.